The reporting of review findings will be guided by PRISMA-ScR. 28 Extracted data will be presented in diagrammatic or tabular form in alignment with scoping review objectives. Specifically, data will ...

Objectives In the UK, there have been a number of national initiatives to promote earlier detection and prompt referral of patients presenting to primary care with signs and symptoms of cancer. The ...

The same information from table 1 may be presented as a bar or a pie chart, which can be prepared considering the absolute or relative frequency of the categories. Figures 2 and 3 illustrate the same ...

Data storytelling is not just a subset of reporting or a more polished presentation, but a method that involves narrative ...

JIANGSU, China and BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui), a global pharmaceutical company focused on scientific and technological innovation, ...

Disc Medicine, Inc. recently provided positive updates on its clinical programs at the EHA 2025 annual meeting in Milan, highlighting favorable long-term efficacy and safety data from its HELIOS ...

Oncoinvent ASA (OSE: ONCIN) a clinical stage radiopharmaceutical company developing innovative treatments for solid cancers, invites for a presentation of the top-line results from the Phase 1/2a ...

ATLANTA, GA- June 10, 2025- GeoVax Labs, Inc., a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies against infectious diseases and solid tumors, today ...

Among the patients with PD-L1 TPS<1%, IBI363 demonstrated outstanding efficacy signals: in the 1/1.5 mg/kg group (N=10), the confirmed ORR was 30.0% and the DCR was 90.0%, while that of the 3 mg ...

Turning tabular data into ‘pseudo-notes’ that mirror clinical documentation allows AI models to analyze patient information ...